当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 现金流量表

润达医疗

(603108)

  

流通市值:58.89亿  总市值:58.89亿
流通股本:6.05亿   总股本:6.05亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,570,730,081.873,583,514,349.161,771,453,008.628,428,657,472.68
  收到的税费返还12,548,886.649,680,806.594,623,517.112,128,631.69
  收到其他与经营活动有关的现金110,516,938.7591,744,195.5348,058,112.74115,995,060.84
  经营活动现金流入小计5,693,795,907.263,684,939,351.281,824,134,638.468,556,781,165.21
  购买商品、接受劳务支付的现金3,841,604,559.582,628,611,528.111,408,094,791.746,126,277,018.84
  支付给职工以及为职工支付的现金492,117,780.2339,409,769.19174,393,116.24701,383,374.7
  支付的各项税费244,071,177.51170,307,657.7974,933,782.62362,760,277.05
  支付其他与经营活动有关的现金391,325,141.74273,326,424.53120,534,205.83729,138,283.85
  经营活动现金流出小计4,969,118,659.033,411,655,379.621,777,955,896.437,919,558,954.44
  经营活动产生的现金流量净额724,677,248.23273,283,971.6646,178,742.03637,222,210.77
二、投资活动产生的现金流量:
  收回投资收到的现金465,200,000289,900,000141,800,000497,040,000
  取得投资收益收到的现金36,914,459.0827,029,975.95437,469.9655,080,960.58
  处置固定资产、无形资产和其他长期资产收回的现金净额7,524,502.773,671,368.291,062,740.6317,818,283.62
  收到的其他与投资活动有关的现金66,694,337.0266,689,125.49954,841.131,500,550
  投资活动现金流入小计576,333,298.87387,290,469.73144,255,051.72571,439,794.2
  购建固定资产、无形资产和其他长期资产支付的现金120,750,399.4686,135,276.6239,102,091.85250,484,597.64
  投资支付的现金437,020,587.29251,116,130.15131,916,130.15559,775,708.93
  支付其他与投资活动有关的现金96,676,674.196,665,523.3996,642,201.19643,594.97
  投资活动现金流出小计654,447,660.85433,916,930.16267,660,423.19810,903,901.54
  投资活动产生的现金流量净额-78,114,361.98-46,626,460.43-123,405,371.47-239,464,107.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,045,714.29400,000-154,285.71
  其中:子公司吸收少数股东投资收到的现金1,045,714.29400,000-154,285.71
  取得借款收到的现金6,227,838,970.184,190,024,642.192,064,673,791.57,579,526,469.12
  收到其他与筹资活动有关的现金500,049,060.01331,015,497200,515,497402,248,095
  筹资活动现金流入小计6,728,933,744.484,521,440,139.192,265,189,288.57,981,928,849.83
  偿还债务支付的现金6,893,160,564.144,489,363,093.912,106,820,591.957,685,740,098.4
  分配股利、利润或偿付利息支付的现金285,711,775.56193,102,078.0592,481,401.55420,996,611.98
  其中:子公司支付给少数股东的股利、利润108,501,625.2666,193,605.2641,411,805.26139,647,221.05
  支付其他与筹资活动有关的现金492,804,200.92342,961,631.27165,856,279.81494,596,421.9
  筹资活动现金流出小计7,671,676,540.625,025,426,803.232,365,158,273.318,601,333,132.28
  筹资活动产生的现金流量净额-942,742,796.14-503,986,664.04-99,968,984.81-619,404,282.45
四、汇率变动对现金及现金等价物的影响-1,409,812.46-1,289,220.89-587,367.3-319,395.78
五、现金及现金等价物净增加额-297,589,722.35-278,618,373.7-177,782,981.55-221,965,574.8
  加:期初现金及现金等价物余额667,045,710.31667,045,710.31667,045,710.31889,011,285.11
  期末现金及现金等价物余额369,455,987.96388,427,336.61489,262,728.76667,045,710.31
补充资料:
  净利润--61,421,266.16--518,150,880.46
  资产减值准备-913,179.76-208,737,137.88
  固定资产和投资性房地产折旧-143,619,209.5-286,439,547.75
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-143,619,209.5-286,439,547.75
  无形资产摊销-11,843,068.04-21,910,565.24
  长期待摊费用摊销-13,679,337.95-28,163,963.57
  处置固定资产、无形资产和其他长期资产的损失-2,146,048.92--3,119,148.21
  固定资产报废损失-4,083,045.82-3,571,120.88
  财务费用-138,991,477.19-279,777,407.24
  投资损失--24,478,851.52--20,792,097.98
  递延所得税--13,544,877.41--56,595,188
  其中:递延所得税资产减少--6,755,759.27--56,818,983.7
    递延所得税负债增加--6,789,118.14-223,795.7
  存货的减少-75,122,237.03--521,072,010.81
  经营性应收项目的减少--342,250,500.4--70,246,852.02
  经营性应付项目的增加-208,473,301.05-748,943,020
  现金的期末余额-388,427,336.61-667,045,710.31
  减:现金的期初余额-667,045,710.31-889,011,285.11
  现金及现金等价物的净增加额--278,618,373.7--221,965,574.8
公告日期2026-10-302026-08-282026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑